






























































A clinical investigation to determine the safety and efficacy of a novel, patented prunus domestica extract in benign prostatic hyperplasia (BPH)
							| Functional Foods in Health and Disease - Online ISSN: 2160-3855; Print ISSN: 2378-7007



	

				
						
 
	Skip to main content
	Skip to main navigation menu
		Skip to site footer


			

				
					
						Open Menu
					
										
																Functional Foods in Health and Disease - Online ISSN: 2160-3855; Print ISSN: 2378-7007
										

				


				
				
					
					
						
																					
				
					Home
				
										
									
										Food Science Publisher
									
								
	
									
										Functional Food Center
									
								


							
	
				
					Current
				
							
	
				
					Archives
				
							
	
				
					About
				
										
									
										About the Journal
									
								
	
									
										Aims and Scope
									
								
	
									
										Contact
									
								
	
									
										Editing Services
									
								
	
									
										Editorial Team
									
								
	
									
										Express Peer Review
									
								
	
									
										Graphical Abstract
									
								
	
									
										Journal Insights
									
								
	
									
										Privacy Statement
									
								
	
									
										Submissions
									
								


							
	
				
					Announcements
				
							
	
				
					Search
				
							



				

																						
									
										
										Search
									
								

													

					

					
								
				
					Register
				
							
	
				
					Login
				
							



					

				
			

		

						
			
				


			
		
			
				Home
			
			/
		
	
			
				Archives
			
			/
		
	
				
					Vol. 15 No. 2 (2025): February 2025
				
				/
			
	
			
									Research Articles
							
		



	
		  	 

		
	
		A clinical investigation to determine the safety and efficacy of a novel, patented prunus domestica extract in benign prostatic hyperplasia (BPH)
	


	
	
		

							
					Authors

						
							
								S.N. Sankhwar
							
																																		
	
							
								Narsingh Verma
							
																																		
	
							
								Naresh Patel
							
																																		
	
							
								Pawan Kumar
							
																																		
	
							
								Apurva Goel
							
																																		
	
							
								Mehul Rungta
							
																																		


				
			
																	
					
												DOI:
					

					
						
							https://doi.org/10.31989/ffhd.v15i2.1556
						
					
				
			

						
										
					Abstract

					Background: Benign Prostate Hyperplasia (BPH) is defined as a non-cancerous enlargement of the prostate gland that is frequently observed in males over 50 years. The major symptoms of the disease involve difficulty urinating, urine dripping, incomplete bladder emptying, and, in severe cases, urine backflow that may lead to kidney infections. Conventional treatments, such as alpha-adrenergic receptor antagonists and Type 2 5-alpha reductase inhibitors, are often associated with significant side effects. In contrast, conventional drugs are based on alpha-adrenergic receptor antagonists or Type 2 5-alpha reductase inhibitors; phototherapeutics —especially phytosterols from the plum family, Prunus domestica and Prunus africana—have shown promise in BPH treatment by lowering prolactin and cholesterol levels in the prostate.

Objectives: This research aimed to conduct a robust clinical trial to evaluate the effects of Prosman™, a novel patented and standardized extract of Prunus domestica, in patients aged 40–65 suffering from BPH.

Material and Methods: An open-labeled single-armed study on 140 male patients of BPH aged 40-65 years. ProsmanTM was administered in a dosage of 100 mg twice a day for 12 weeks, with follow-ups at weeks 4, 8, and 12. Efficacy was evaluated through biochemical tests, including blood tests for Prostate-Specific Antigen (PSA), ultrasound, and urinary flow tests. Safety was assessed through analysis of various blood parameters, including hemoglobin, total leukocyte count, differential leucocyte count, SGOT, SGPT, and ALP levels, along with monitoring urea and creatinine levels.

Results: Prunus Domestica extract (ProsmanTM) was efficacious and effective in alleviating BPH in subjects, as confirmed, evidenced by a reduction in IPSS score, prostate volume, and serum PSA levels. No significant adverse changes were observed in the hematological parameters.

Conclusion: Prunus Domestica extract (ProsmanTM) can, therefore, be explored as a safe and effective phototherapeutics for the development of novel treatment procedures for BPH.

Keywords: Benign Prostatic Hyperplasia (BPH); Prunus domestica; Clinical Investigation; Urinary dysfunction, prostate enlargement; Prostate specific antigen (PSA); Ultrasound; Safety

				
			
			

						
																																																						
						
		


		

						
										
					
						Downloads
					

						
								
	
													


		
	[Abstract]

	
							
	
								
	
													


		
	[Full Article]

	
							


				

						
						
				
					
						Published
					

					
																			2025-03-01
																	

				
							

			
						
										

											
							
								Issue
							

							
								
									Vol. 15 No. 2 (2025): February 2025
								
							

						
					
											
							
								Section
							

							
								Research Articles
							

						
					
									

			
						
										
					
						License
					

																										Copyright (c) 2025 Functional Foods in Health and Disease

														This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

																Authors retain the copyright of their articles and grant the Functional Food Center (FFC) and its journals the right of first publication under the terms of the Creative Commons Attribution 4.0 International License.

This license permits unrestricted use, distribution, and reproduction in any medium, including commercial use, provided the original author(s) and source are properly credited. Authors may post and share their published work freely, provided that the original publication in this journal is acknowledged.

By submitting to this journal, authors confirm that their manuscripts are original, not under consideration elsewhere, and that they hold the necessary rights to grant this license. The Functional Food Center encourages open scientific exchange and allows derivative and extended works, provided attribution to the original publication is maintained.

				

			
			

		

	




	




	


							



	

	

					
				About the Journal      Editing Services      Graphical Abstract      Journal Insights        Submissions        Editorial Team       Privacy Statement        Contact        Current        Archives

 

			

		
		Open Journal Systems Hosting and Support by: OpenJournalSystems.com


	










